SCHEMBL6530788

SCHEMBL6530788

CCc1c(C(=O)O)cc(-c2csc(C)n2)n1Cc1ccc(OC)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.44
HTT P42858 1/20 0.44
PPARG P37231 2/20 0.41
CCR2 P41597 1/20 0.41
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ECE1 P42892 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ERCC5 P28715 1/20 0.38
FABP4 P15090 1/20 0.38
MAPT P10636 1/20 0.38
AGTR1 P30556 1/20 0.38
AGTR2 P50052 1/20 0.38
USP2 O75604 1/20 0.37
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5044005 0.89 LMNA (0.46) LMNAHTTPPARGCCR2NPC1
SCHEMBL5045711 0.79 KDM4E (0.55) PPARGNPC1RAB9AKDM4EALDH1A1
SCHEMBL5048561 0.77 PPARD (0.48) CCR2NPC1RAB9AMEN1KMT2A
SCHEMBL6471994 0.76 KDM4E (0.51) CCR2NPC1RAB9AMEN1KMT2A
SCHEMBL5044546 0.76 SREBF2 (0.49) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL6879060 0.75 KDM4E (0.53) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL5901687 0.75 CDK5 (0.47) PPARGNPC1RAB9AMEN1KMT2A
SCHEMBL5044175 0.74 EIF4E (0.49) PPARGNPC1RAB9AKDM4EALDH1A1
SCHEMBL6881059 0.74 EIF4E (0.50) PPARGNPC1RAB9AKDM4EALDH1A1
SCHEMBL5044780 0.74 KDM4E (0.48) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1583762-A1 PYRROLYL-THIAZOLES AND THEIR USE AS CB 1 RECEPTOR INVERSE AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2005-10-12 EP disclosed
WO-2004060888-A1 NOVEL CB 1 RECEPTOR INVERSE AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2004-07-22 WO disclosed